BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26191180)

  • 1. MiR-302a inhibits the tumorigenicity of ovarian cancer cells by suppression of SDC1.
    Guo T; Yu W; Lv S; Zhang C; Tian Y
    Int J Clin Exp Pathol; 2015; 8(5):4869-80. PubMed ID: 26191180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression.
    Chen WT; Yang YJ; Zhang ZD; An Q; Li N; Liu W; Yang B
    J Ovarian Res; 2017 Jan; 10(1):1. PubMed ID: 28086946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-302a targets GAB2 to suppress cell proliferation, migration and invasion of glioma.
    Ma J; Yu J; Liu J; Yang X; Lou M; Liu J; Feng F; Ji P; Wang L
    Oncol Rep; 2017 Feb; 37(2):1159-1167. PubMed ID: 28000880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
    Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
    Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-140-5p inhibits ovarian cancer growth partially by repression of PDGFRA.
    Lan H; Chen W; He G; Yang S
    Biomed Pharmacother; 2015 Oct; 75():117-22. PubMed ID: 26297547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.
    Ma J; Li D; Kong FF; Yang D; Yang H; Ma XX
    J Exp Clin Cancer Res; 2018 Feb; 37(1):19. PubMed ID: 29391048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1.
    Guo LM; Pu Y; Han Z; Liu T; Li YX; Liu M; Li X; Tang H
    FEBS J; 2009 Oct; 276(19):5537-46. PubMed ID: 19702828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival.
    Fu X; Li Y; Alvero A; Li J; Wu Q; Xiao Q; Peng Y; Hu Y; Li X; Yan W; Guo K; Zhou W; Wang Y; Liu J; Zhang Y; Mor G; Wen J; Yin G
    Oncotarget; 2016 Dec; 7(49):80633-80654. PubMed ID: 27811362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma.
    Zou YT; Gao JY; Wang HL; Wang Y; Wang H; Li PL
    Genet Mol Res; 2015 Jul; 14(3):8766-77. PubMed ID: 26345808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-302a sensitizes testicular embryonal carcinoma cells to cisplatin-induced cell death.
    Liu L; Lian J; Zhang H; Tian H; Liang M; Yin M; Sun F
    J Cell Physiol; 2013 Dec; 228(12):2294-304. PubMed ID: 23625774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
    Liu X; Li G
    Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
    Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
    PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-145 function as a cell growth repressor by directly targeting c-Myc in human ovarian cancer.
    Zhang W; Wang Q; Yu M; Wu N; Wang H
    Technol Cancer Res Treat; 2014 Apr; 13(2):161-8. PubMed ID: 23919393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-498 regulated FOXO3 expression and inhibited the proliferation of human ovarian cancer cells.
    Liu R; Liu F; Li L; Sun M; Chen K
    Biomed Pharmacother; 2015 May; 72():52-7. PubMed ID: 26054675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1.
    Yang Y; Tao X; Li CB; Wang CM
    Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-1297 regulates hepatocellular carcinoma cell proliferation and apoptosis by targeting EZH2.
    Liu F; He Y; Shu R; Wang S
    Int J Clin Exp Pathol; 2015; 8(5):4972-80. PubMed ID: 26191190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
    Zhang X; Huang L; Zhao Y; Tan W
    Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
    Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
    Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-718 represses VEGF and inhibits ovarian cancer cell progression.
    Leng R; Zha L; Tang L
    FEBS Lett; 2014 Jun; 588(12):2078-86. PubMed ID: 24815691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.